Moura, Ines B. http://orcid.org/0000-0002-3019-7196
Normington, Charmaine
Ewin, Duncan
Clark, Emma
Wilcox, Mark H.
Buckley, Anthony M.
Chilton, Caroline H.
Funding for this research was provided by:
Seres Therapeutics (Not applicable)
Leeds Cares (3R02 _93)
Rosetrees Trust (A1332)
Article History
Received: 7 August 2019
Accepted: 1 December 2019
First Online: 2 January 2020
Ethics approval and consent to participate
: The collection/use of faecal donations from healthy adult volunteers following informed verbal consent was approved by the Leeds Institute of Health Sciences and Leeds Institute of Genetics, Health and Therapeutics and Leeds Institute of Molecular Medicine, University of Leeds joint ethics committee (reference HSLTLM/12/061). All volunteers received a participant information document at least 24 h prior to sample collection; this leaflet details the study purpose, why the research is needed and instructions to use the collection kit. When chosen to participate, the volunteers provide the faecal sample to the research team with the understanding that they consented to that sample being used solely for gut model projects. The long-term storage of donor faecal samples for the <i>in vitro</i> gut model experiments was approved by the East Midlands – Leicester South Research Ethics Committee (REC number: 16\EM\0263), IRAS project identification 206,781.
: Not applicable.
: IBM has received support to attend meetings from Techlab. AMB has received research funding from Seres, Motif Biosciences, Nabriva, Tetraphase, and Hayashibara Co. CHC has received research funding from Astellas Pharma Europe, Da Volterra and Cubist Pharmaceuticals and support to attend meetings from Astellas. MHW has received honoraria for consultancy work, financial support to attend meetings and research funding from Astellas, AstraZeneca, Abbott, Actelion, Alere, AstraZeneca, Bayer, bioMérieux, Cerexa, Cubist, Da Volterra, Durata, Merck, Nabriva, Pfizer, Qiagen, Roche, Seres, Synthetic Biologics, Summit and The Medicines Company. All other authors: declare.that they have no competing interest.